{"id":256351,"date":"2014-07-04T20:49:09","date_gmt":"2014-07-05T00:49:09","guid":{"rendered":"http:\/\/www.eugenesis.com\/global-nanomedicine-market-projected-to-be-worth-usd-177-60-billion-by-2019\/"},"modified":"2014-07-04T20:49:09","modified_gmt":"2014-07-05T00:49:09","slug":"global-nanomedicine-market-projected-to-be-worth-usd-177-60-billion-by-2019","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/global-nanomedicine-market-projected-to-be-worth-usd-177-60-billion-by-2019.php","title":{"rendered":"Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019"},"content":{"rendered":"<p><p>    Albany, New York (PRWEB) July 04, 2014  <\/p>\n<p>    The new title on Nanomedicine Market (Neurology,    Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology    Applications) - Global Industry Analysis, Size, Share, Growth,    Trends and Forecast, 2013 - 2019,\" predicts that the total    nanomedicine market globally will be worth USD 177.60 billion    by 2019, growing considerably from its 2012 value of USD 78.54    billion. This market is expected to achieve a compounded annual    growth rate of 12.3% between 2013 and 2019.  <\/p>\n<p>    Browse Nanomedicine Market Research Report with full TOC:        <a href=\"http:\/\/www.transparencymarketresearch.com\/nanomedicine-market.html\" rel=\"nofollow\">http:\/\/www.transparencymarketresearch.com\/nanomedicine-market.html<\/a>.  <\/p>\n<p>    The report talks about the major growth areas of within the    nanomedicine market over the period of forecast. The    introduction of new technologies and applications in this    sector will propel growth to a significant degree at the global    level. Further, the initiatives taken by various governments as    well as privately-funded institutions towards promoting the    commercialization of new nanomedicine products will boost this    market. The report also dwells on the role played by the rising    geriatric population base, the prevalence of medical needs that    are in need of treatment, as well as the rising incidence of    chronic diseases globally.  <\/p>\n<p>    Make and inquiry:     <a href=\"http:\/\/www.transparencymarketresearch.com\/sample\/sample.php?flag=S&#038;rep_id=1753\" rel=\"nofollow\">http:\/\/www.transparencymarketresearch.com\/sample\/sample.php?flag=S&#038;rep_id=1753<\/a>.  <\/p>\n<p>    According to the report, the leading application segment within    the nanomedicine market was that of oncology, holding a 38%    share of the overall market in 2012, as a vast number of    commercially available products prevail in this sector. The    development of nanomedicine-based treatments and products that    are able to directly target tumors in the brain and other    bodily sites is poised to be a significant factor affecting    growth in this market.  <\/p>\n<p>    Though the largest market segment within the nanomedicine    market is that of oncology, the fastest growing segment is the    cardiovascular market. According to the Transparency Market    Research report, growth in this segment has been fuelled by the    presence of a sizeable patient population, and a simultaneous    growth in the demand for device and drugs that are based on    nanomedicine. These factors are collectively anticipated to    further fuel the growth of the cardiovascular segment within    the nanomedicine market.  <\/p>\n<p>    Request for customization for this report:     <a href=\"http:\/\/www.transparencymarketresearch.com\/sample\/sample.php?flag=S&#038;rep_id=1753\" rel=\"nofollow\">http:\/\/www.transparencymarketresearch.com\/sample\/sample.php?flag=S&#038;rep_id=1753<\/a>.  <\/p>\n<p>    The report also carries out an in-depth analysis of the    regional market share based on the applications, revenue, and    products. According to the report, the nanomedicine market was    largely dominated by North America in 2012. It is expected that    this regional market will continue to hold its leading position    in the way over the forecast period until 2019. Though the    larger market share will be held by North America, it is    anticipated that the fastest growing market, by region, will be    Asia-Pacific. The report states that the CAGR recorded by the    Asia-Pacific market will be 14.6% between 2013 and 2019.  <\/p>\n<p>    Furthermore, the analysis of the regional markets also    concludes that the Europe region is predicted to show a growth    rate thats relatively higher than that of North America.    Factors that are likely to cause this increased growth rate    include: an improvement in the regulatory framework as well as    the presence of a wide-ranging product portfolio in the    pipeline, set to be introduced by leading market players.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" href=\"http:\/\/www.prweb.com\/releases\/2014\/07\/prweb11995415.htm\/RK=0\/RS=XSQsHZ5w4GnQnVy4Myl5G6pjIdw-\" title=\"Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019\">Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> Albany, New York (PRWEB) July 04, 2014 The new title on Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,\" predicts that the total nanomedicine market globally will be worth USD 177.60 billion by 2019, growing considerably from its 2012 value of USD 78.54 billion. This market is expected to achieve a compounded annual growth rate of 12.3% between 2013 and 2019 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nanomedicine-2\/global-nanomedicine-market-projected-to-be-worth-usd-177-60-billion-by-2019.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577779],"tags":[],"class_list":["post-256351","post","type-post","status-publish","format-standard","hentry","category-nanomedicine-2"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256351"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=256351"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/256351\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=256351"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=256351"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=256351"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}